Immunolocalization of Kim-1, RPA-1, and RPA-2 in Kidney of Gentamicin-, Mercury-, or Chromium-Treated Rats: Relationship to Renal Distributions of iNOS and Nitrotyrosine
暂无分享,去创建一个
Ronald P. Brown | J. Bonventre | Jun Zhang | V. Vaidya | N. Sadrieh | P. Goering | P. Espandiari | Martin Shaw | M. Stratmeyer | Yuzhao Zhou | C. Kilty | J. Keenan
[1] B. Rosenzweig,et al. Age‐related differences in susceptibility to cisplatin‐induced renal toxicity , 2009, Journal of applied toxicology : JAT.
[2] J. Bonventre,et al. Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. , 2008, Kidney international.
[3] Jun Zhang,et al. The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[4] M. C. V. D. Heuvel,et al. Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease , 2007, The Journal of pathology.
[5] Ximing J. Yang,et al. Human Kidney Injury Molecule-1 (hKIM-1): A Useful Immunohistochemical Marker for Diagnosing Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma , 2007, The American journal of surgical pathology.
[6] Martin Shaw,et al. Histologically defined biomarkers in toxicology , 2007, Expert opinion on drug safety.
[7] H. van Goor,et al. Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis. , 2007, Kidney international.
[8] P. Cristofori,et al. Renal Proximal Tubule Segment-Specific Nephrotoxicity: An Overview on Biomarkers and Histopathology , 2007, Toxicologic pathology.
[9] Joseph V Bonventre,et al. Mechanistic biomarkers for cytotoxic acute kidney injury , 2006, Expert opinion on drug metabolism & toxicology.
[10] S. Bakker,et al. Tubular kidney injury molecule-1 in protein-overload nephropathy. , 2006, American journal of physiology. Renal physiology.
[11] R. Jain,et al. The role of nitric oxide in tumour progression , 2006, Nature Reviews Cancer.
[12] M. Takaoka,et al. RETRACTION: Opposite Effects of Pre- and Postischemic Treatments with Nitric Oxide Donor on Ischemia/Reperfusion-Induced Renal Injury , 2006, Journal of Pharmacology and Experimental Therapeutics.
[13] Joseph V Bonventre,et al. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. , 2006, American journal of physiology. Renal physiology.
[14] N. Rifai,et al. Mechanisms and Biomarkers of Cardiovascular Injury Induced by Phosphodiesterase Inhibitor III SK&F 95654 in the Spontaneously Hypertensive Rat , 2006, Toxicologic pathology.
[15] M. Faghihi,et al. Effects of nitric oxide on gentamicin toxicity in isolated perfused rat kidneys. , 2005, Journal of nephrology.
[16] J. Pedraza-Chaverri,et al. Time course study of oxidative and nitrosative stress and antioxidant enzymes in K2Cr2O7-induced nephrotoxicity , 2005, BMC nephrology.
[17] H. Parlakpınar,et al. Protective role of caffeic acid phenethyl ester (cape) on gentamicin-induced acute renal toxicity in rats. , 2005, Toxicology.
[18] Rafael Radi,et al. Nitric oxide, oxidants, and protein tyrosine nitration , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Bonventre,et al. Kidney Injury Molecule-1 ( Kim-1 ) : A Tissue and Urinary Biomarker for Nephrotoxicant-Induced Renal Injury . , 2003 .
[20] Timothy A Bertram,et al. Identification of putative gene based markers of renal toxicity. , 2004, Environmental health perspectives.
[21] J. Pedraza-Chaverri,et al. Aged garlic extract attenuates gentamicin induced renal damage and oxidative stress in rats. , 2003, Life sciences.
[22] Paul L Huang,et al. Inducible Nitric-oxide Synthase Is an Important Contributor to Prolonged Protective Effects of Ischemic Preconditioning in the Mouse Kidney* , 2003, Journal of Biological Chemistry.
[23] Sudhir V. Shah,et al. Apoptotic pathways of oxidative damage to renal tubular epithelial cells. , 2002, Antioxidants & redox signaling.
[24] S. Somlo,et al. Kidney injury molecule-1 expression in murine polycystic kidney disease. , 2002, American journal of physiology. Renal physiology.
[25] Merlin C. Thomas,et al. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. , 2002, Diabetes.
[26] T. Yokozawa,et al. Potential of Sanguiin H-6 against Oxidative Damage in Renal Mitochondria and Apoptosis Mediated by Peroxynitrite in vivo , 2002, Nephron.
[27] J. Bonventre,et al. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. , 2002, Kidney international.
[28] M. Goligorsky,et al. Nitric oxide in acute renal failure: NOS versus NOS. , 2002, Kidney international.
[29] Debasis Bagchi,et al. Chromium (VI)‐induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene , 2001, Molecular and Cellular Biochemistry.
[30] M. Yaqoob,et al. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. , 2000, Kidney international.
[31] S. Shah,et al. Oxidant mechanisms in toxic acute renal failure. , 1999, Drug metabolism reviews.
[32] F. Murad,et al. Nitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry. , 1999, American journal of physiology. Renal physiology.
[33] G. Schlüter,et al. Urinary antigens as markers of papillary toxicity. II: Application of monoclonal antibodies for the determination of papillary antigens in rat urine , 1999, Archives of Toxicology.
[34] F. Park,et al. Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney. , 1999, American journal of physiology. Renal physiology.
[35] O. Wada,et al. Inducible nitric oxide synthase expression in mercury chloride-induced acute tubular necrosis. , 1998, Industrial health.
[36] R. Nemenoff,et al. Effect of hypoxia on proximal tubules isolated from nitric oxide synthase knockout mice. , 1998, Kidney international.
[37] Joseph V. Bonventre,et al. Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury* , 1998, The Journal of Biological Chemistry.
[38] G. Diamond,et al. Understanding Renal Toxicity of Heavy Metals , 1998, Toxicologic pathology.
[39] S. Bachmann,et al. Immunohistochemically detected protein nitration indicates sites of renal nitric oxide release in Goldblatt hypertension. , 1997, Hypertension.
[40] Division on Earth. Guide for the Care and Use of Laboratory Animals , 1996 .
[41] K. Ahn,et al. In situ hybridization localization of mRNA encoding inducible nitric oxide synthase in rat kidney. , 1994, The American journal of physiology.
[42] N. Holstein-Rathlou,et al. Effect of cisplatin on proximal convoluted and straight segments of the rat kidney. , 1988, The Journal of pharmacology and experimental therapeutics.
[43] S. Sternberg,et al. The renal pathology in clinical trials of Cis‐platinum (II) diamminedichloride , 1977, Cancer.
[44] Ronald P. Brown,et al. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[45] L. Liaudet,et al. Nitric oxide and peroxynitrite in health and disease. , 2007, Physiological reviews.
[46] R. D. de Boer,et al. Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. , 2007, American journal of physiology. Renal physiology.
[47] Martin Shaw. The use of histologically defined specific biomarkers in drug development with special reference to the glutathione S-transferases. , 2005, Cancer Biomarkers.
[48] G. Daugaard,et al. Cisplatin nephrotoxicity , 2004, Cancer Chemotherapy and Pharmacology.
[49] T. Billiar,et al. Role of NO and Nitrogen Intermediates in Regulation of Cell Functions , 1997 .
[50] S. Bachmann. Distribution of NOSs in the Kidney , 1997 .
[51] G. Schlüter,et al. Urinary antigens as markers of papillary toxicity. I Identification and characterization of rat kidney papillary antigens with monoclonal antibodies , 1996, Archives of Toxicology.
[52] K. Meyer,et al. Cisplatin nephrotoxicity. , 1994, Mineral and electrolyte metabolism.
[53] S. Gambaryan,et al. Age dependent differences in the functional and morphological impairment of kidney following cisplatin administration. , 1990, Experimental pathology.
[54] N. Holstein-Rathlou,et al. Functional and histopathological changes in dog kidneys after administration of cisplatin. , 1987, Renal physiology.